Get started
Author

Lucia Appolloni

Carbapenem-resistant bacteria in an intensive care unit during the coronavirus disease 2019 (COVID-19) pandemic: A multicenter before-and-after cross-sectional study
2021 · Renato Pascale, Linda Bussini, et al. · Infection Control and Hospital Epidemiology · 96
PDF
Doravirine/lamivudine/tenofovir disoproxil fumarate in virologically suppressed people living with HIV: A real-life experience
2023 · Leonardo Calza, Vincenzo Colangeli, et al. · International Journal of STD & AIDS · 19
Skeletal Muscle Toxicity in HIV-1-Infected Patients Treated with a Raltegravir-Containing Antiretroviral Therapy: A Cohort Study
2014 · Leonardo Calza, Ilaria Danese, et al. · AIDS Research and Human Retroviruses · 15
Omega-3 for the prevention of cardiovascular diseases: meta-analysis and trial-sequential analysis
2020 · Maria Francesca Cabiddu, Alberto Russi, et al. · European Journal of Hospital Pharmacy · 10
Changes in Serum Inflammatory Markers in Antiretroviral Therapy–Naive HIV-Infected Patients Starting Dolutegravir/Lamivudine or Tenofovir Alafenamide/Emtricitabine/Bictegravir
2022 · Leonardo Calza, Isabella Bon, et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 5
A prospective evaluation of maraviroc administration in patients with advanced HIV disease and multiple comorbidities: focus on efficacy and tolerability issues.
2015 · Roberto Manfredi, Leonardo Calza, et al. · PubMed · 4
Raltegravir use prospectively assessed in a major HIV outpatient clinic in Italy: sample population, virological-immunological activity, and tolerability profile.
2014 · Roberto Manfredi, Leonardo Calza, et al. · PubMed · 2
Decrease in drug-drug interactions between antiretroviral drugs and concomitant therapies in older people living with HIV-1 switching to bictegravir/emtricitabine/tenofovir alafenamide.
2025 · Leonardo Calza, Maddalena Giglia, et al. · PubMed · 1
P-122 The use of pre-exposure prophylaxis (PrEP) in the control of HIV infection and other sexually transmitted diseases (STDs). Descriptive-observational analysis in an Italian polyclinic
2024 · D Cicetti, S Vitale, et al. · Sexually Transmitted Infections · 1
PDF
Integration among hospital pharmacists and infectious diseases physicians in the outpatient management of HIV infection.
2014 · Lucia Appolloni, Federica Locchi, et al. · PubMed · 1
Decrease in drug-drug interactions between antiretroviral drugs and concomitant therapies in older people living with HIV-1 switching to bictegravir/emtricitabine/tenofovir alafenamide
2025 · Calza L, Giglia M, et al. · Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna)
PDF
P-9 Cost/effectiveness analysis and assessment of adverse events associated with the administration of the long-acting cabotegravir – rilpivirine association
2024 · D Cicetti, S Vitale, et al. · Sexually Transmitted Infections
PDF
2257. BDG-Guided Management of Empirical Antifungal Therapy: a Real-life Experience in a Hospital-Wide Context with High Incidence of Non-albicans Candida Infection
2019 · Lorenzo Marconi, Angelo Maccaro, et al. · Open Forum Infectious Diseases
Direct acting antivirals for the treatment of elderly patients with HCV advanced disease in the real life practice
2016 · F. Conti, A. Scuteri, et al. · Digestive and Liver Disease
Treatment with direct acting antiviral agents-based regimen in HCV patients with advanced liver disease: Analysis of an Italian multicenter observational study
2016 · F. Conti, A. Scuteri, et al. · Digestive and Liver Disease
DGI-046 Monitoring of Adherence to Treatment and Adverse Events in the Management of Patients with HIV Infection
2013 · L Appolloni, F Locchi, et al. · European Journal of Hospital Pharmacy
PDF
Works count: 17
Citation count: 154
H-index: 5
I10-index: 4
Year
Topic
Type